| Literature DB >> 19394218 |
Young Lok Choi1, Joa Kyum Kim, Sang-Un Choi, Yong-Ki Min, Myung-Ae Bae, Bum Tae Kim, Jung-Nyoung Heo.
Abstract
A series of natural aristolactams and their analogues have been prepared and evaluated for antitumor activity against human cancer cells, including multi-drug resistant cell lines. Naturally occurring aristolactams, such as aristolactam BII (cepharanone B), aristolactam BIII, aristolactam FI (piperolactam A), N-methyl piperolactam A, and sauristolactam showed moderate antitumor activities in selected cell lines. However, several synthetic aristolactam derivatives exhibited potent antitumor activities against a broad array of cancer cell lines with GI(50) values in the submicromolar range.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19394218 DOI: 10.1016/j.bmcl.2009.04.020
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823